LONDON--(BUSINESS WIRE)--As a part of its new healthcare provider analytics article series, Quantzig, a premier analytics services provider, today announced the completion of its recent case study – ‘Global Healthcare Conglomerate Improves Quality Adherence in Clinical Trials Using Pharmacovigilance Analytics’
The case study also offers comprehensive insights on:
- The benefits of pharmacovigilance in improving safety reporting in clinical trials
- How to improve process safety during clinical trials
Quantzig’s analytics experts help pharmaceutical companies to optimize strategic clinical processes by combining data, analytics and technology. Get in touch with them to know more.
For companies in the pharmaceutical industry, it is difficult to analyze the vast amounts of raw, unstructured patient data. Safety reporting in clinical trials requires tested statistical methods that have to be specified with the regulatory authorities before the trial even begins.
At Quantzig, we analyze the current business scenario using real-time dashboards to help global enterprises operate more efficiently. Our ability to help performance-driven organizations realize their strategic and operational goals within a short span using data-driven insights has helped us gain a leading edge in the analytics industry. To help businesses ensure business continuity amid the crisis, we’ve curated a portfolio of advanced healthcare provider analytics solutions that not just focus on improving profitability but help enhance stakeholder value, boost customer satisfaction, and help achieve financial objectives.
Quantzig’s data analytics solutions are specifically designed to help healthcare organizations enhance the safety reporting in clinical trials. Request a free demo to know more.
“The pharma industry is not the only stakeholder of pharmacovigilance, but surely the primary stakeholder, thus companies must focus on safety reporting in clinical trials” says an analytics expert at Quantzig.
Business Outcomes
1: Improved trial accountability
2: Prevented serious safety risks
Through the insights from pharmacovigilance analytics, the client improved the accountability for drug development clinical trials, ensured regulatory compliance through documentation, and was able to conclude the study meeting all the safety objectives. Our safety reporting clinical trials help companies to analyze performance of critical trial data in real-time. Request a free proposal to gain in-depth insights into our portfolio of analytics solutions.
Quantzig’s Healthcare Analytics Capabilities Include:
- Clinical trial reporting and analytics
- Pharmacovigilance analytics
- Drug pricing and promotion analytics
- Patient analytics
To know more about our healthcare provider analytics solutions, visit: https://bit.ly/35UwFyK
About Quantzig
Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit: https://www.quantzig.com/request-for-proposal
